Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026

Silo Pharma, Inc.

Every 15 shares of common stock combined into 1 share; par value unchanged at $0.0001.
Authorized shares reduced proportionately from 100M to approximately 6.67M.
Fractional shares rounded up to the next whole share; no fractional shares issued.
Common stock trades under same symbol SILO but with new CUSIP 82711P 300.
Split-adjusted trading began on The Nasdaq Capital Market on June 3, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.